Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Study

NCT02996032 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT02996032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Study
Lead sponsor
Boston Medical Center
Phase
Observational
Overall status
Completed
Start date
November 30, 2016
Completion date
April 30, 2018
Enrollment
187 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure